Diagnosis of chronic pancreatitis

Initial Clues - The Grumbling Gland

• Clinical Triad (often incomplete):

  • Pain: Persistent, deep epigastric pain radiating to the back. Often postprandial, leading to food avoidance and weight loss.
  • Malabsorption (Exocrine Insufficiency): Steatorrhea (bulky, foul-smelling, fatty stools), weight loss, and fat-soluble vitamin (A, D, E, K) deficiencies.
  • Diabetes Mellitus (Endocrine Insufficiency): Late finding; often brittle and difficult to control.

• Lab Findings:

  • Serum amylase & lipase are typically normal or only mildly elevated, unlike in acute pancreatitis.
  • ↓ Fecal elastase is a more sensitive indicator of exocrine dysfunction.

• Etiology:

  • 📌 TIGAR-O Mnemonic: Toxic-metabolic (alcohol, smoking), Idiopathic, Genetic, Autoimmune, Recurrent acute pancreatitis, Obstructive.

⭐ Amylase and lipase levels are often normal in chronic pancreatitis due to burnout of acinar cells, distinguishing it from acute pancreatitis where levels are significantly elevated.

Imaging Modalities - Pancreas Paparazzi

• CT Abdomen: Often the first-line imaging modality.
  • Key findings: Pancreatic calcifications (pathognomonic), main pancreatic duct dilation (>3 mm), and parenchymal atrophy. Limited sensitivity for early disease.
• MRI / MRCP: Superior to CT for visualizing ductal anatomy, strictures, and pseudocysts without radiation.
  • Secretin-stimulated MRCP (s-MRCP) dynamically assesses exocrine function by measuring duodenal filling.
• Endoscopic Ultrasound (EUS): Highly sensitive and specific for both early and late-stage disease.
  • Detects subtle parenchymal (e.g., lobularity) and ductal changes.
  • Guided by Rosemont criteria for diagnosis.
• ERCP: Historically the gold standard for visualizing ductal morphology (Cambridge classification).
  • Invasive with significant risk of post-procedure pancreatitis; now reserved for therapeutic interventions.

⭐ Chain of Lakes: A classic, exam-favorite finding on MRCP or ERCP, representing alternating stenosis and dilation of the main pancreatic duct.

Function Tests - The Final Proof

• Confirms exocrine insufficiency when imaging is inconclusive, especially in early disease.

• Direct Test (Most Sensitive):

  • Secretin Stimulation Test: Involves duodenal intubation to collect pancreatic fluid after IV secretin.
  • Measures bicarbonate output; a concentration < 80 mEq/L is diagnostic.
  • Highly sensitive and specific but invasive and rarely performed.

• Indirect Tests (Non-Invasive):

  • Fecal Elastase-1: Preferred initial test. Measures enzyme concentration in stool.
    • Unaffected by pancreatic enzyme replacement therapy (PERT).
    • Value < 200 µg/g suggests insufficiency.
  • 72-hour Fecal Fat: Measures steatorrhea on a 100 g/day fat diet.
    • Result > 7 g/day is abnormal.

⭐ Fecal elastase is a practical, non-invasive first choice for suspected pancreatic exocrine insufficiency, though its sensitivity is lower in mild cases compared to the secretin test.

High‑Yield Points - ⚡ Biggest Takeaways

• Amylase/lipase are often normal, a key distinction from acute pancreatitis.
• The classic triad of pancreatic calcifications, steatorrhea, and diabetes mellitus indicates late-stage disease.
• CT abdomen is the best initial imaging to detect calcifications and ductal dilation.
• MRCP or EUS are the most sensitive imaging modalities for diagnosing early or mild chronic pancreatitis.
• The secretin stimulation test is the most specific test for pancreatic exocrine function, though rarely used.
• Fecal elastase is a reliable, non-invasive test for pancreatic exocrine insufficiency.